Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00903630 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

Interventions

DRUG: Lenalidomide
DRUG: liposomal doxorubicin

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]